Evidence map›Paper›PMID 29673363›Full record

ArticleBMC veterinary research2018

Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.

Tatjana Sattler, Jutta Pikalo, Eveline Wodak, Sandra Revilla-Fernández, Adi Steinrigl, Zoltán Bagó, Ferdinand Entenfellner, Jean-Baptiste Claude, Floriane Pez, Maela Francillette and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Tatjana SattlerInstitute for Veterinary Disease Control, AGES, Robert-Koch-Gasse 17, 2340, Mödling, Austria. tasat@vetmed.uni-leipzig.de.ORCID http://orcid.org/0000-0001-8946-6699
Jutta PikaloInstitute for Veterinary Disease Control, AGES, Robert-Koch-Gasse 17, 2340, Mödling, Austria.
Eveline WodakInstitute for Veterinary Disease Control, AGES, Robert-Koch-Gasse 17, 2340, Mödling, Austria.
Sandra Revilla-FernándezInstitute for Veterinary Disease Control, AGES, Robert-Koch-Gasse 17, 2340, Mödling, Austria.
Adi SteinriglInstitute for Veterinary Disease Control, AGES, Robert-Koch-Gasse 17, 2340, Mödling, Austria.
Zoltán BagóInstitute for Veterinary Disease Control, AGES, Robert-Koch-Gasse 17, 2340, Mödling, Austria.
Ferdinand EntenfellnerVeterinary Practice Entenfellner, Bonnleiten 8, 3073, Stössing, Austria.
Jean-Baptiste ClaudeBioSellal, Bâtiment Accinov, 317 avenue Jean Jaurès, 69007, Lyon, France.
Floriane PezBioSellal, Bâtiment Accinov, 317 avenue Jean Jaurès, 69007, Lyon, France.
Maela FrancilletteBioSellal, Bâtiment Accinov, 317 avenue Jean Jaurès, 69007, Lyon, France.
Friedrich SchmollInstitute for Veterinary Disease Control, AGES, Robert-Koch-Gasse 17, 2340, Mödling, Austria.
University of Veterinary Medicine Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEffective vaccines against porcine reproductive and respiratory syndrome virus (PRRSV), especially against highly pathogenic (HP) PRRSV are still missing. The objective of this study was to evaluate the protective efficacy of an experimental live attenuated PRRSV 2 vaccine, composed of two strains, against heterologous challenge with a Vietnamese HP PRRSV 2 field strain. For this reason, 20 PRRSV negative piglets were divided into two groups. The pigs of group 1 were vaccinated with the experimental vaccine, group 2 remained unvaccinated. All study piglets received an intranasal challenge of the HP PRRSV 2 on day 0 of the study (42 days after vaccination). Blood samples were taken on days 7 and 21 after vaccination and on several days after challenge. On day 28 after challenge, all piglets were euthanized and pathologically examined.

resultsOn days 7 and 21 after vaccination, a PRRSV 2 viraemia was seen in all piglets of group 1 which remained detectable in seven piglets up to 42 days after vaccination. On day 3 after challenge, all piglets from both groups were positive in PRRSV 2 RT-qPCR. From day 7 onwards, viral load and number of PRRSV 2 positive pigs were lower in group 1 than in group 2. All pigs of group 1 seroconverted after PRRSV 2 vaccination. PRRSV antibodies were detected in serum of all study pigs from both groups from day 14 after challenge onwards. In group 2, moderate respiratory symptoms with occasional coughing were seen following the challenge with HP PRRSV 2. Pigs of group 1 remained clinically unaffected. Interstitial pneumonia was found in four piglets of group 1 and in all ten piglets of group 2. Histopathological findings were more severe in group 2.

conclusionsIt was thus concluded that the used PRRSV 2 live experimental vaccine provided protection from clinical disease and marked reduction of histopathological findings and viral load in pigs challenged with a Vietnamese HP PRRSV 2 field strain.

Indexed as

AnimalsEnzyme-Linked Immunosorbent AssayMalePorcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusReal-Time Polymerase Chain ReactionRNA, ViralSequence Analysis, DNASwineTreatment OutcomeVaccines, AttenuatedViral VaccinesRNA, ViralVaccines, AttenuatedViral VaccinesEfficacyHP PRRSV 2Immune responseVaccineViral replication

Identifiers

PMID29673363
PMCPMC5907707
OpenAlexW2804625537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.